Trends of biomolecule-conjugated nanoparticles as antibiofilm

IF 3.5 3区 医学 Q3 IMMUNOLOGY Microbial pathogenesis Pub Date : 2025-05-01 Epub Date: 2025-02-18 DOI:10.1016/j.micpath.2025.107396
Nourhan G. Naga , Habiba M. Magdy , Sally Negm , Attalla F. El-kott , Mohammed A. AlShehri , Mohammad M. El-Metwally , Sahar E. Abo-Neima , Emad M. Elsehly
{"title":"Trends of biomolecule-conjugated nanoparticles as antibiofilm","authors":"Nourhan G. Naga ,&nbsp;Habiba M. Magdy ,&nbsp;Sally Negm ,&nbsp;Attalla F. El-kott ,&nbsp;Mohammed A. AlShehri ,&nbsp;Mohammad M. El-Metwally ,&nbsp;Sahar E. Abo-Neima ,&nbsp;Emad M. Elsehly","doi":"10.1016/j.micpath.2025.107396","DOIUrl":null,"url":null,"abstract":"<div><div>Biofilm is a powerful barrier that significantly enhances the pathogenicity of bacteria and the development of multidrug resistance. Nanoparticles (NPs) coupled with biomolecules provide a novel approach to addressing this issue. This review briefly discusses the current trends in Biomolecule-Conjugated NPs combined with enzymes, antibiotics, biosurfactants, and natural bioactive compounds as antibiofilm agents emphasizing their superior antibiofilm activity. This conjugation enhances bioavailability, lowers toxicity, requires smaller dosage, and reduces complications caused by infections associated with biofilms. These conjugated systems offer an avenue for industrial, ecological, and medical applications. By increasing the variety of these conjugation techniques, innovative approaches to biofilm-related problems will become possible, with significant advantages for healthcare and other fields.</div></div>","PeriodicalId":18599,"journal":{"name":"Microbial pathogenesis","volume":"202 ","pages":"Article 107396"},"PeriodicalIF":3.5000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial pathogenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0882401025001214","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Biofilm is a powerful barrier that significantly enhances the pathogenicity of bacteria and the development of multidrug resistance. Nanoparticles (NPs) coupled with biomolecules provide a novel approach to addressing this issue. This review briefly discusses the current trends in Biomolecule-Conjugated NPs combined with enzymes, antibiotics, biosurfactants, and natural bioactive compounds as antibiofilm agents emphasizing their superior antibiofilm activity. This conjugation enhances bioavailability, lowers toxicity, requires smaller dosage, and reduces complications caused by infections associated with biofilms. These conjugated systems offer an avenue for industrial, ecological, and medical applications. By increasing the variety of these conjugation techniques, innovative approaches to biofilm-related problems will become possible, with significant advantages for healthcare and other fields.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生物分子共轭纳米颗粒抗生物膜研究进展。
生物膜是一种强大的屏障,可以显著增强细菌的致病性和产生多药耐药性。纳米粒子(NPs)与生物分子的耦合为解决这一问题提供了一种新的途径。本文简要介绍了生物分子共轭NPs与酶、抗生素、生物表面活性剂和天然生物活性化合物联合作为抗生物膜剂的研究进展,重点介绍了其具有良好的抗生物膜活性。这种结合提高了生物利用度,降低了毒性,需要更小的剂量,并减少了与生物膜相关的感染引起的并发症。这些共轭系统为工业、生态和医疗应用提供了一条途径。通过增加这些缀合技术的多样性,生物膜相关问题的创新方法将成为可能,对医疗保健和其他领域具有显著的优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Microbial pathogenesis
Microbial pathogenesis 医学-免疫学
CiteScore
7.40
自引率
2.60%
发文量
472
审稿时长
56 days
期刊介绍: Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports. Research Areas Include: -Pathogenesis -Virulence factors -Host susceptibility or resistance -Immune mechanisms -Identification, cloning and sequencing of relevant genes -Genetic studies -Viruses, prokaryotic organisms and protozoa -Microbiota -Systems biology related to infectious diseases -Targets for vaccine design (pre-clinical studies)
期刊最新文献
The gut microbiome as a modulator of antibiotic resistance: Mechanisms, dynamics, and therapeutic interventions Bifidobacterium longum subsp. infantis B8762 modulates the infant gut-lung axis via microbial and metabolic reprogramming The ESX-3 secretion system in mycobacteria: Evolution, structure, and multifunctional roles in pathogenesis Genomic analysis and pathogenic characterization of novel PRRSV-1 strain HBEU-328 in North China Beyond antibody titers: Corticosteroid effects on IgG avidity dynamics in experimental strongyloidiasis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1